Treatment as prevention - A double hat-trick

The Lancet

Volumn 378, Issue 9787, 2011, Pages 209-211

  Montaner, Julio Sg ^a,b,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

^c Providence Health Care in Vancouver   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; COST MINIMIZATION ANALYSIS; DRUG CONTROL; DRUG COST; DRUG DELIVERY SYSTEM; DRUG FORMULATION; HEALTH CARE ACCESS; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LOWEST INCOME GROUP; MEDICAL LITERATURE; MIDDLE INCOME GROUP; NOTE; POINT OF CARE TESTING; PRIORITY JOURNAL; SCALE UP; SOCIOECONOMICS; TREATMENT PLANNING;

EID: 79960357727     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)60247-X     Document Type: Note

References (18)

1. International Treatment as Prevention Workshop Vancouver, BC, Canada http://www.cfenet.ubc.ca/events/international-workshop-treatment-prevention May 4-6, 2011 (accessed May 21, 2011).
2. AS Sturt, EK Dokubo, TT Sint Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women Cochrane Database Syst Rev 3 2010 CD008440.
3. D Donnell, JM Baeten, J Kiarie et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis Lancet 375 2010 2092 2098
4. E Wood, T Kerr, BDL Marshall et al. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study BMJ 338 2009 b1649 10.1136/bmj.b1649
5. G Kirk, N Galai, J Astemborski et al. Decline in community viral load strongly associated with declining HIV incidence among IDU. 18th Conference on Retroviruses and Opportunistic Infections; Boston, MA, USA; Feb 27-March 2, 2011: 484 (abstr) http://www.retroconference.org/2011/Abstracts/42134.htm (accessed May 21, 2011).
6. CT Fang, HM Hsu, SJ Twu et al. Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan J Infect Dis 190 2004 879 885
7. JSG Montaner, R Hogg, E Wood et al. The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic Lancet 368 2006 531 536 (Pubitemid 44142776)
8. JSG Montaner, VD Lima, R Barrios et al. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study Lancet 376 2010 532 539
9. M Das, PL Chu, GM Santos et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco PLoS One 5 2010 e11068
10. National Institute of Allergy and Infectious Diseases Treating HIV-infected people with antiretrovirals protects partners from infection: findings result from NIH-funded international study http://www.niaid.nih.gov/ news/newsreleases/2011/Pages/HPTN052.aspx May 12, 2011 (accessed May 12, 2011).
11. National Institute of Allergy and Infectious Diseases The HPTN 052 Study: Preventing Sexual Transmission of HIV with Anti-HIV Drugs http://www.niaid.nih. gov/news/QA/Pages/HPTN052qa.aspx May 12, 2011 (accessed May 12, 2011).
12. The Lancet HIV treatment as prevention - it works Lancet 377 2011 1719
13. N Volkow, J Montaner Enhanced HIV testing, treatment, and support for HIV-infected substance users JAMA 303 2010 1423 1424
14. VD Lima, K Johnston, RS Hogg et al. Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the epidemic J Infect Dis 198 2008 59 67 (Pubitemid 351920290)
15. RM Granich, CF Gilks, C Dye, KM DeCock, BG Williams Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model Lancet 373 2009 48 57
16. BG Wagner, JS Kahn, S Blower Should we try to eliminate HIV epidemics by using a "Test and Treat" strategy? AIDS 24 2010 775 776
17. International Treatment as Prevention Workshop WHO references for ART in prevention http://www.cfenet.ubc.ca/node/5543 (accessed May 21, 2011).
18. CW Dieffenbach, AS Fauci Universal voluntary testing and treatment for prevention of HIV transmission JAMA 301 2009 2380 2382